Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial.
作者信息
Soran Atilla, Özbaş Serdar, Doğan Lütfi, Sezgin Efe, Özmen Vahit, Beriwal Sushil, Brufsky Adam
出版信息
Eur J Breast Health. 2020 Jun 8;16(3):158-159. doi: 10.5152/ejbh.2020.080620. eCollection 2020 Jul.
Abstract
摘要
相似文献
1
Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 Trial.新发转移性乳腺癌患者原发肿瘤完整的局部区域治疗；ECOG-ACRIN 2108试验的评论与关注
Eur J Breast Health. 2020 Jun 8;16(3):158-159. doi: 10.5152/ejbh.2020.080620. eCollection 2020 Jul.
2
Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry.局部晚期转移性乳腺癌局部治疗的发病率：对监测、流行病学和最终结果（SEER）-医疗保险登记处的分析。
Breast Cancer Res Treat. 2018 Jun;169(2):287-293. doi: 10.1007/s10549-018-4689-y. Epub 2018 Jan 27.
3
Results of ECOG-ACRIN E2108 Trial: Is This the End of Primary Surgery in Metastatic Breast Cancer?ECOG-ACRIN E2108试验结果：这是转移性乳腺癌原发手术的终结吗？
Eur J Breast Health. 2020 Dec 24;17(1):84-85. doi: 10.4274/ejbh.2020.6222. eCollection 2021 Jan.
4
Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?接受辅助全身治疗患者的腋窝淋巴结包膜外扩展：放疗指征？
Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9. doi: 10.1016/s0360-3016(97)89483-7.
5
Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit?转移性乳腺癌患者的局部区域治疗：是否有生存获益？
Breast Cancer Res Treat. 2010 Feb;119(3):537-45. doi: 10.1007/s10549-009-0610-z.
6
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.局部晚期直肠癌患者术前放疗联合卡培他滨、奥沙利铂和贝伐单抗，随后手术及术后使用5-氟尿嘧啶、亚叶酸钙、奥沙利铂（FOLFOX）和贝伐单抗的II期试验：5年临床结果 ECOG-ACRIN癌症研究组E3204
Oncologist. 2015 Jun;20(6):615-6. doi: 10.1634/theoncologist.2015-0106. Epub 2015 Apr 29.
7
Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?新发转移性乳腺癌原发肿瘤的手术治疗：做还是不做？
Eur J Surg Oncol. 2015 Oct;41(10):1288-92. doi: 10.1016/j.ejso.2015.07.013. Epub 2015 Jul 29.
8
Predictors of loco-regional recurrence and cancer-related death after breast cancer surgery.乳腺癌手术后局部区域复发和癌症相关死亡的预测因素。
Breast J. 2010 Sep-Oct;16 Suppl 1:S29-33. doi: 10.1111/j.1524-4741.2010.01000.x.
9
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?转移性乳腺癌的预后：初发性和复发性转移性乳腺癌患者之间存在差异吗？
Br J Cancer. 2015 Apr 28;112(9):1445-51. doi: 10.1038/bjc.2015.127. Epub 2015 Apr 16.
10
Pattern of follow-up care and early relapse detection in breast cancer patients.乳腺癌患者的随访护理和早期复发检测模式。
Breast Cancer Res Treat. 2012 Dec;136(3):859-68. doi: 10.1007/s10549-012-2297-9. Epub 2012 Nov 2.
引用本文的文献
1
Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions.乳腺癌寡转移和寡进展的诊治：现状与未来方向。
Curr Oncol Rep. 2024 Jun;26(6):647-664. doi: 10.1007/s11912-024-01529-2. Epub 2024 Apr 23.
2
Aggressive local therapy for metastatic breast cancer: Challenges and updates (Review).转移性乳腺癌的积极局部治疗：挑战与更新（综述）。
Oncol Rep. 2023 Sep;50(3). doi: 10.3892/or.2023.8600. Epub 2023 Jul 14.
3
The Role of Primary Surgery in Metastatic Breast Carcinoma.原发性手术在转移性乳腺癌中的作用
Eur J Breast Health. 2023 Apr 1;19(2):110-114. doi: 10.4274/ejbh.galenos.2023.2023-3-7. eCollection 2023 Apr.
4
Metastatic breast cancer: Who benefits from surgery?转移性乳腺癌：哪些人从手术中获益？
Am J Surg. 2022 Jan;223(1):81-93. doi: 10.1016/j.amjsurg.2021.07.018. Epub 2021 Jul 22.
5
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.局部区域治疗新诊断转移性乳腺癌：系统评价和荟萃分析。
Breast. 2021 Aug;58:173-181. doi: 10.1016/j.breast.2021.05.003.
6
Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China.局部区域手术在初诊IV期乳腺癌患者中的作用：来自中国的真实世界数据分析
Sci Rep. 2020 Oct 22;10(1):18132. doi: 10.1038/s41598-020-75119-0.
Zotero 插件